Twist Bioscience Corporation
139.92USD
+4.4500 (+3.28%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TWST.
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* |
|---|---|---|---|---|---|---|---|---|
| Revenue | 118 | 111 | 104 | 99 | 96 | 93 | 89 | 85 |
| Cost of Revenue | 56 | 54 | 50 | 48 | 45 | 47 | 46 | 46 |
| Gross Profit | 62 | 57 | 54 | 51 | 51 | 46 | 43 | 38 |
| Operating Income | -36 | -46 | -33 | -30 | -30 | -42 | -35 | -36 |
| Net Income | -35 | -44 | -31 | -27 | 20 | -39 | -32 | -35 |
| EPS (Diluted) | -$0.56 | -$0.71 | -$0.50 | -$0.45 | $0.33 | -$0.66 | -$0.53 | -$0.59 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)